Localizing central nervous system immune surveillance: Meningeal antigen‐presenting cells activate T cells during experimental autoimmune encephalomyelitis
暂无分享,去创建一个
[1] Hans Lassmann,et al. Multiple sclerosis and Alzheimer's disease , 2008, Annals of neurology.
[2] R. Reynolds,et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.
[3] P. Sawchenko,et al. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis , 2007, The Journal of comparative neurology.
[4] Hans Lassmann,et al. Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.
[5] S. Cepok,et al. Immune surveillance in multiple sclerosis patients treated with natalizumab , 2006, Annals of neurology.
[6] R. Ransohoff,et al. The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.
[7] R. Fujinami,et al. Multiple sclerosis and virus induced immune responses: Autoimmunity can be primed by molecular mimicry and augmented by bystander activation , 2006, Autoimmunity.
[8] N. Huang,et al. B Cells Productively Engage Soluble Antigen-Pulsed Dendritic Cells: Visualization of Live-Cell Dynamics of B Cell-Dendritic Cell Interactions , 2005, The Journal of Immunology.
[9] V. Kuchroo,et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity , 2005, Nature Immunology.
[10] Britta Engelhardt,et al. The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis , 2005, Cerebrospinal Fluid Research.
[11] B. Engelhardt,et al. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. , 2005, Trends in immunology.
[12] Tobias Bonhoeffer,et al. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion , 2005, The Journal of experimental medicine.
[13] L. Steinman,et al. Multiple sclerosis: trapped in deadly glue , 2005, Nature Medicine.
[14] S. Miller,et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis , 2005, Nature Medicine.
[15] B. Becher,et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis , 2005, Nature Medicine.
[16] B. Becher,et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.
[17] B. Serafini,et al. Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.
[18] E. Baba,et al. Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells. , 2004, Journal of immunological methods.
[19] R. Ransohoff,et al. The Activation Status of Neuroantigen-specific T Cells in the Target Organ Determines the Clinical Outcome of Autoimmune Encephalomyelitis , 2004, The Journal of experimental medicine.
[20] S. Henrickson,et al. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.
[21] P. McMenamin,et al. Macrophages and dendritic cells in the rat meninges and choroid plexus: three-dimensional localisation by environmental scanning electron microscopy and confocal microscopy , 2003, Cell and Tissue Research.
[22] R. Ransohoff,et al. Three or more routes for leukocyte migration into the central nervous system , 2003, Nature Reviews Immunology.
[23] R. Ransohoff,et al. Recovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7‐1/B7‐2‐deficient mice , 2003, European journal of immunology.
[24] R. Ransohoff,et al. Human cerebrospinal fluid central memory CD4+ T cells: Evidence for trafficking through choroid plexus and meninges via P-selectin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Weiner,et al. Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis , 2003, The Journal of experimental medicine.
[26] Sabine Stoll,et al. Imaging of T‐cell interactions with antigen presenting cells in culture and in intact lymphoid tissue , 2002, Immunological reviews.
[27] Michael Loran Dustin,et al. T Cell Receptor Signaling Precedes Immunological Synapse Formation , 2002, Science.
[28] Eugene C. Butcher,et al. Molecular Mechanisms Involved in Lymphocyte Recruitment in Inflamed Brain Microvessels: Critical Roles for P-Selectin Glycoprotein Ligand-1 and Heterotrimeric Gi-Linked Receptors1 , 2002, The Journal of Immunology.
[29] P. Popovich,et al. Alterations in immune cell phenotype and function after experimental spinal cord injury. , 2001, Journal of neurotrauma.
[30] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[31] S. Khoury,et al. CD28-independent induction of experimental autoimmune encephalomyelitis. , 2001, The Journal of clinical investigation.
[32] E. Bröcker,et al. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. , 2000, Immunity.
[33] C. Janeway,et al. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. , 2000, Brain : a journal of neurology.
[34] W. Hickey,et al. Leukocyte traffic in the central nervous system: the participants and their roles. , 1999, Seminars in immunology.
[35] C. Granger,et al. Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis 1 Studies supported by the National Multiple Sclerosis Society (grants RG2019, RG2827); the NINDS (NS26321); and Biogen Inc. 1 , 1999, Journal of Neuroimmunology.
[36] P. Rakić,et al. Changes in cell-cycle kinetics during the development and evolution of primate neocortex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Gibbs,et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.
[38] B. Engelhardt,et al. Lymphocyte Targeting of the Central Nervous System: A Review of Afferent and Efferent CNS‐Immune Pathways , 1996, Brain pathology.
[39] L. Picker,et al. Lymphocyte Homing and Homeostasis , 1996, Science.
[40] S. Younkin,et al. Amyloid β protein levels in cerebrospinal fluid are elevated in early‐onset Alzheimer's disease , 1994 .
[41] S. Harik. Cerebrospinal Fluid in Diseases of the Nervous System, 2nd Ed. , 1994, Neurology.
[42] M. Sofroniew,et al. Serum Proteins Bypass the Blood-Brain Fluid Barriers for Extracellular Entry to the Central Nervous System , 1993, Experimental Neurology.
[43] R. Fishman. Cerebrospinal Fluid in Diseases of the Nervous System , 1992 .
[44] W. Hickey. Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS Inflammation , 1991, Brain pathology.
[45] C. Brosnan,et al. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[46] W. Hickey,et al. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. , 1988, Science.
[47] H. Wiśniewski,et al. Chronic relapsing EAE time course of neurological symptoms and pathology , 1978, Acta Neuropathologica.
[48] R. Adams,et al. A histologic study of the early lesion in experimental allergic encephalomyelitis in the guinea pig and rabbit. , 1962, The American journal of pathology.
[49] R. Reynolds,et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.
[50] C. Granger,et al. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. , 1999, Journal of neuroimmunology.
[51] S. Younkin,et al. Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. , 1994, Annals of Neurology.
[52] P. Knopf,et al. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. , 1992, Immunology today.